Vanguard Global Advisers’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$947K Buy
88,418
+4,773
+6% +$36.9K ﹤0.01% 1778
2026
Q1
$533K Buy
+83,645
New +$582K ﹤0.01% 2010

Other funds holding LFST

Vanguard Global Advisers's LFST Position: Q2 2026 in Review

Vanguard Global Advisers increased its Lifestance Health (LFST) stake by 5.7% in Q2 2026, buying an estimated $36.9K and bringing the position to 88,418 shares worth $947K. The position accounts for ﹤0.01% of the portfolio, ranked #1778.

Vanguard Global Advisers first reported a position in LFST in Q1 2026 and has held it in 2 quarters since. 285 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Vanguard Global Advisers held 88,418 shares of Lifestance Health worth $947K as of Q2 2026.
  • Vanguard Global Advisers bought 4,773 Lifestance Health shares in Q2 2026, an estimated $36.9K.
  • Lifestance Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1778 holding.
  • Vanguard Global Advisers first reported a position in Lifestance Health in Q1 2026 and has held it in 2 quarters since.
  • 285 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.